SEC Form 4 · accession 0001179110-15-002009
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Capek
Officer — Executive Vice President
Period of report
Feb 4, 2015
Accepted (ET)
Feb 6, 2015 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 4, 2015 | S | 3,900 | $45.82 | D | 232,980 | D | |
| Common shares without par value | Feb 4, 2015 | S | 800 | $45.825 | D | 232,180 | D | |
| Common shares without par value | Feb 4, 2015 | S | 100 | $45.8275 | D | 232,080 | D | |
| Common shares without par value | Feb 4, 2015 | S | 1,935 | $45.83 | D | 230,145 | D | |
| Common shares without par value | Feb 4, 2015 | S | 200 | $45.835 | D | 229,945 | D | |
| Common shares without par value | Feb 4, 2015 | S | 100 | $45.8375 | D | 229,845 | D | |
| Common shares without par value | Feb 4, 2015 | S | 300 | $45.845 | D | 229,545 | D | |
| Common shares without par value | Feb 4, 2015 | S | 2,200 | $45.85 | D | 227,345 | D | |
| Common shares without par value | Feb 4, 2015 | S | 400 | $45.86 | D | 226,945 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 3 of 3.